Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,252 | 723 | 99.7% |
| Education | $38.53 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,224 | 112 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,815 | 69 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,226 | 44 | $0 (2024) |
| Amgen Inc. | $1,139 | 47 | $0 (2024) |
| Lilly USA, LLC | $1,135 | 71 | $0 (2024) |
| ABBVIE INC. | $1,070 | 58 | $0 (2024) |
| GlaxoSmithKline, LLC. | $950.36 | 51 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $675.61 | 26 | $0 (2024) |
| PFIZER INC. | $652.95 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $505.96 | 26 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,990 | 81 | AstraZeneca Pharmaceuticals LP ($325.69) |
| 2023 | $2,009 | 98 | AstraZeneca Pharmaceuticals LP ($461.11) |
| 2022 | $2,507 | 109 | Boehringer Ingelheim Pharmaceuticals, Inc. ($346.20) |
| 2021 | $2,946 | 152 | AbbVie Inc. ($366.53) |
| 2020 | $2,333 | 131 | Novo Nordisk Inc ($389.71) |
| 2019 | $853.79 | 44 | Novo Nordisk Inc ($232.88) |
| 2018 | $936.45 | 44 | Novo Nordisk Inc ($438.75) |
| 2017 | $1,716 | 71 | Novo Nordisk Inc ($390.27) |
All Payment Transactions
730 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: VACCINE | ||||||
| 12/10/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Neurology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $103.86 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.09 | General |
| 10/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Neuromodulation | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Neurology | ||||||
| 10/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: VACCINES | ||||||
| 09/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: PAIN | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: VACCINE | ||||||
| 09/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Oncology | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Hematology | ||||||
| 08/22/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $64.32 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 205 | 418 | $113,096 | $35,100 |
| 2022 | 7 | 287 | 463 | $108,160 | $39,831 |
| 2021 | 7 | 328 | 520 | $62,637 | $41,547 |
| 2020 | 7 | 258 | 390 | $47,157 | $23,848 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 307 | $89,644 | $26,331 | 29.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 38 | 38 | $11,324 | $4,797 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 58 | $11,948 | $3,929 | 32.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 14 | 15 | $180.00 | $42.13 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 112 | 266 | $68,624 | $21,691 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 53 | 53 | $14,730 | $7,013 | 47.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 79 | $14,404 | $4,829 | 33.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 15 | 15 | $6,750 | $4,171 | 61.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $1,952 | $1,097 | 56.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $950.00 | $575.70 | 60.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 15 | 15 | $750.00 | $454.50 | 60.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 276 | $37,492 | $24,407 | 65.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 50 | 50 | $8,170 | $6,740 | 82.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 116 | $11,104 | $6,715 | 60.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $3,000 | $1,312 | 43.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 19 | 19 | $1,425 | $1,240 | 87.0% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 19 | 20 | $800.00 | $800.00 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 19 | 19 | $646.00 | $333.83 | 51.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 80 | 174 | $27,136 | $12,176 | 44.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 66 | 96 | $9,876 | $4,773 | 48.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 37 | 37 | $4,765 | $4,364 | 91.6% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 17 | 17 | $2,550 | $2,015 | 79.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 16 | 17 | $765.00 | $289.17 | 37.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 13 | 13 | $570.00 | $125.26 | 22.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 29 | 36 | $1,495 | $106.68 | 7.1% |
About Dr. Daniel Rasor, M.D
Dr. Daniel Rasor, M.D is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043211329.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Rasor, M.D has received a total of $15,291 in payments from pharmaceutical and medical device companies, with $1,990 received in 2024. These payments were reported across 730 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($15,252).
As a Medicare-enrolled provider, Rasor has provided services to 1,078 Medicare beneficiaries, totaling 1,791 services with total Medicare billing of $140,326. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 08/09/2005
- Last Updated 04/28/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1043211329
Products in Payments
- JARDIANCE (Drug) $1,429
- Ozempic (Drug) $1,176
- FARXIGA (Drug) $763.34
- UBRELVY (Drug) $733.63
- TRELEGY ELLIPTA (Drug) $683.52
- Kerendia (Drug) $675.61
- BREZTRI (Drug) $546.44
- Repatha (Biological) $466.64
- XARELTO (Drug) $416.11
- Vascepa (Drug) $344.89
- VRAYLAR (Drug) $317.84
- Victoza (Drug) $315.81
- EMGALITY (Drug) $301.76
- Otezla (Drug) $292.97
- Aimovig (Biological) $217.57
- Saxenda (Drug) $215.53
- TRULICITY (Drug) $210.77
- Dayvigo (Drug) $190.46
- AIRSUPRA (Drug) $186.89
- MOUNJARO (Drug) $181.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768